These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11416610)

  • 21. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.
    Dahlöf B; Degl' Innocenti A; Elmfeldt D; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Tanser P; Toutouzas P; Waeber B; Wiklund I
    Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group.
    Elliott WJ; Montoro R; Smith D; Leibowitz M; Hwang C; Gradman AH; Schleman M; Klibaner M
    Am J Hypertens; 1999 Jul; 12(7):691-6. PubMed ID: 10411366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.
    Haria M; Plosker GL; Markham A
    Drugs; 2000 Jan; 59(1):141-57. PubMed ID: 10718104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benazepril versus felodipine as supplement to bendroflumethiazide: evaluation by office and ambulatory blood pressure.
    Kristensen KS; Wiinberg N; Høegholm A; Kornerup HJ; Svendsen TL; Mølby L; Pindborg T; Nielsen PE
    Blood Press Monit; 1998 Apr; 3(2):115-120. PubMed ID: 10212340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of metoprolol succinate extended release vs. amlodipine besylate on the blood pressure, heart rate, and the rate-pressure product in patients with hypertension.
    White WB; Krishnan S; Giacco S; Mallareddy M
    J Am Soc Hypertens; 2008; 2(5):378-84. PubMed ID: 20409919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension-Do These Differ From the U.S. Recommendations? Which Guidelines Should the Practicing Physician Follow?
    Moser M
    J Clin Hypertens (Greenwich); 1999 Jul; 1(1):48-54. PubMed ID: 11416593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study.
    Lin MS; Chan KA; Wang CH; Chang NC
    Curr Ther Res Clin Exp; 2004 Mar; 65(2):204-21. PubMed ID: 24936117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of a switch to fixed-dose combination therapy with amlodipine besylate/benazepril hydrochloride after monotherapy with amlodipine besylate: Data from the African-American subpopulation of a practice-based, open-label study (the LOGIC study).
    Gatlin M; Jarrett WG; Nwose OM;
    Curr Ther Res Clin Exp; 2004 Mar; 65(2):138-48. PubMed ID: 24936113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension in Older Persons.
    Cushman WC; Black HR
    J Clin Hypertens (Greenwich); 1999 Jul; 1(1):55-61. PubMed ID: 11416594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol.
    Sowers JR; Raman BB; Afonso LC; Bedford-Rice K; Standley PR
    J Hum Hypertens; 1996 Mar; 10(3):177-80. PubMed ID: 8733036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self Reported Sexual Dysfunction in Men and Women Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Amlodipine, Placebo, or Bisoprolol/Hydrochlorothiazide.
    Prisant LM; Weir MR; Frishman WH; Neutel JM; Davidov ME; Lewin AJ
    J Clin Hypertens (Greenwich); 1999 Jul; 1(1):22-26. PubMed ID: 11416589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.